Anne Houdusse

29PUBLICATIONS

53CO-AUTHORS

Cardiology (incl. cardiovascular diseases)Medical infection agents (incl. prions)Energy generation, conversion and storage (excl. chemical and electrical)Characterisation of biological macromoleculesRegenerative medicine (incl. stem cells)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (29)

Sort by Publication Date:

|Jun 04, 2026

Dynamics of the β-cardiac myosin auto-inhibited state explain cardiomyopathy pathogenesis.

|Oct 01, 2025

Hypertrophic cardiomyopathy mutations Y115H and E497D disrupt the folded-back state of human β-cardiac myosin allosterically.

Neha Nandwani, Debanjan Bhowmik, Camille Glaser

|Jun 12, 2025

Modulation of Filopodial Myosin Function.

Amy Crawford, Jessica K Schwartz, Emerson Hall

|Apr 07, 2025

Coupling between the lever arm and active site via an N-terminal extension tunes force sensitivity in the myosin-1 family.

Harry W Rathbone, Anne Houdusse

|Oct 17, 2024

Development of Clinically Viable Non-Muscle Myosin II Small Molecule Inhibitors with Broad Therapeutic Potential.

Laszlo Radnai, Erica J Young, Carlos Kikuti

|Aug 28, 2024

Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy.

James J Hartman, Darren T Hwee, Julien Robert-Paganin

Pageof 5

Frequent Collaborators

7 joint publications

Daniel Auguin

7 joint publications

Julien Robert-Paganin

Carlos Kikuti

James A Spudich

Neha Nandwani

Kathleen M Ruppel

Jake Baum

James J Hartman

H Lee Sweeney

Marco Cecchini

Frequent Collaborators

7 joint publications

Daniel Auguin

7 joint publications

Julien Robert-Paganin

6 joint publications

Carlos Kikuti

4 joint publications

James A Spudich